Differences in the incidence and mortality rate of prostate cancer between the USA and
Japan have been decreasing over time, and were only twofold in 2017. Therefore …

These guidelines cover a wide range of topics from prostate cancer epidemiology to
palliative care. Questions arising in daily clinical practice have been extracted and …

Objective To assess the value of a positive family history (FH) as a risk factor for prostate
cancer incidence and grade among men undergoing organised prostate‐specific antigen …

Abstract Background Studies conducted in Swedish populations have shown that men with
lowest prostate-specific antigen (PSA) levels at ages 44–50 years and 60 years have very …

Background Prostate-specific antigen (PSA)–based screening for prostate cancer has been
widely performed, but its accuracy is unsatisfactory. To improve accuracy, building an …

Objective To assess the value of positive family history (FH) as a risk factor for prostate
cancer (PCa) incidence and grade among men undergoing organized PSA-screening in a …

Introduction We researched the usefulness of optimizing prostate cancer (PC) screening in
our community using baseline PSA readings in men between 40 and 49 years of age …

This study aimed to investigate the optimal screening interval of a prostate specific antigen
(PSA) screening program for men aged 40–70 with a baseline PSA< 2 ng/mL in China. 8 …

O adenocarcinoma da próstata é uma das neoplasias mais frequentes no género masculino
em Portugal e a nível mundial. O antigénio específico prostático (PSA) tem sido utilizado …

Prostatakarzinome sind ausgesprochen heterogen. Gut differenzierte, klinisch häufig als
insignifikant bezeichnete Tumoren erhöhen die Inzidenz und verwässern die biologische …